UCLA Health
At UCLA Health, we provide the best health care, using the latest medical technology — healing humankind one patient at a time.
- 2024 Heart Failure Symposium
- 17th Annual UCLA Liver Diseases Symposium
- 12th Annual UCLA-Mellinkoff GI and Hepatology Symposium
- Personalized Nutrition in Primary Care 2024
- 2023 Heart Failure Symposium
- 2023 UCLA ECMO and Life Support Symposium
- 11th Annual UCLA-Mellinkoff GI and Hepatology Symposium
- 15th Annual UCLA Liver Diseases Symposium
- Neurosurgery
- Nephrology
- Cardiovascular
- Oncology
- Liver Grand Rounds
- Liver Hour
- Gastroenterology
- Advanced Lung Disease and Lung Transplantation Symposium 2023
- 16th Annual UCLA Liver Diseases Symposium
- Personalized Nutrition 2022
- 2024 Advanced Lung Disease and Lung Transplantation Symposium
- Events
Playback speed
10 seconds
Efficacy and Toxicity of 177Lu-PSMA-617 for mCRPC: Results From the U.S. Expanded Access Program & Comparison With Phase 3 VISION Data
By
UCLA Health
FEATURING
Vishnu Murthy
By
UCLA Health
FEATURING
Vishnu Murthy
3 views
November 20, 2024
Comments 0
Login to view comments.
Click here to Login